Fig. 3.

ASCVD score and proportion of patients with high ASCVD risk according to NFS-defined significant liver fibrosis stratified by the CNS-defined NAFLD/obesity status. Lean subjects with NFS-defined significant liver fibrosis had a significantly higher ASCVD score (A) and prevalence of a high ASCVD risk (B) than obese subjects with significant liver fibrosis and those without significant liver fibrosis (all p<0.001).

ASCVD, atherosclerotic cardiovascular disease; NAFLD, nonalcoholic fatty liver disease; NFS, NAFLD fibrosis score; CNS, comprehensive NAFLD score.